
Amanda L. Aguirre
Examiner (ID: 17942, Phone: (571)272-5592 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 850 |
| Issued Applications | 613 |
| Pending Applications | 94 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10703452
[patent_doc_number] => 20160049599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES'
[patent_app_type] => utility
[patent_app_number] => 14/796213
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11951
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796213
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796213 | Electroluminescent (2-phenylpyridine)iridium complexes and devices | Jul 9, 2015 | Issued |
Array
(
[id] => 11756419
[patent_doc_number] => 20170203286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'IONIC LIQUID, ADDUCT AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/324785
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10947
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324785
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324785 | IONIC LIQUID, ADDUCT AND METHODS THEREOF | Jul 8, 2015 | Abandoned |
Array
(
[id] => 12979639
[patent_doc_number] => 20170342084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/324528
[patent_app_country] => US
[patent_app_date] => 2015-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -198
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324528 | REDUCTION OF ALPHA, BETA-UNSATURATED KETONE LEVELS IN MORPHINAN DERIVATIVE COMPOSITIONS | Jul 7, 2015 | Abandoned |
Array
(
[id] => 12546066
[patent_doc_number] => 10011561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Thickening/stabilizing agent and thickened/stabilized composition using the same
[patent_app_type] => utility
[patent_app_number] => 15/323627
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6317
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/323627 | Thickening/stabilizing agent and thickened/stabilized composition using the same | Jul 6, 2015 | Issued |
Array
(
[id] => 11729226
[patent_doc_number] => 20170190670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/325085
[patent_app_country] => US
[patent_app_date] => 2015-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5962
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325085 | IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE | Jul 5, 2015 | Abandoned |
Array
(
[id] => 11669886
[patent_doc_number] => 20170158607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'ORGANOCATALYTIC ASYMMETRIC SYNTHESIS OF ANTIDEPRESSANTS'
[patent_app_type] => utility
[patent_app_number] => 15/320483
[patent_app_country] => US
[patent_app_date] => 2015-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4796
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320483
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320483 | Organocatalytic asymmetric synthesis of antidepressants | Jun 21, 2015 | Issued |
Array
(
[id] => 11555113
[patent_doc_number] => 20170101359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENOL'
[patent_app_type] => utility
[patent_app_number] => 15/317912
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3118
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317912 | Process for preparing 3-chloro-2-vinylphenol | Jun 7, 2015 | Issued |
Array
(
[id] => 11542575
[patent_doc_number] => 20170096399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 15/316100
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80070
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316100
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316100 | Pyrazole compounds and their use as T-type calcium channel blockers | Jun 1, 2015 | Issued |
Array
(
[id] => 11555123
[patent_doc_number] => 20170101369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'SULFONAMIDE COMPOUNDS AND THEIR USE AS STAT5 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/315324
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31256
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/315324 | Sulfonamide compounds and their use as STAT5 inhibitors | May 28, 2015 | Issued |
Array
(
[id] => 14057763
[patent_doc_number] => 10233165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Cyclopropylamine compounds as histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/314851
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 14637
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314851 | Cyclopropylamine compounds as histone demethylase inhibitors | May 28, 2015 | Issued |
Array
(
[id] => 12486633
[patent_doc_number] => 09993482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/314167
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7619
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314167
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314167 | Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer | May 25, 2015 | Issued |
Array
(
[id] => 11684905
[patent_doc_number] => 09682938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Pyrazolone derivatives as nitroxyl donors'
[patent_app_type] => utility
[patent_app_number] => 14/722141
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 188954
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14722141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/722141 | Pyrazolone derivatives as nitroxyl donors | May 25, 2015 | Issued |
Array
(
[id] => 12286051
[patent_doc_number] => 09932339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Helquats with heteroaromatic substituents, preparation thereof, and use thereof as G-quadruplex stabilizers
[patent_app_type] => utility
[patent_app_number] => 15/313492
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 13115
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 314
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313492 | Helquats with heteroaromatic substituents, preparation thereof, and use thereof as G-quadruplex stabilizers | May 25, 2015 | Issued |
Array
(
[id] => 11480362
[patent_doc_number] => 09586890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods'
[patent_app_type] => utility
[patent_app_number] => 14/721829
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 124
[patent_no_of_words] => 30906
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14721829
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/721829 | Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods | May 25, 2015 | Issued |
Array
(
[id] => 14359965
[patent_doc_number] => 10301269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Imidazole derivatives as formyl peptide receptor modulators
[patent_app_type] => utility
[patent_app_number] => 15/312367
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16932
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 682
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312367
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312367 | Imidazole derivatives as formyl peptide receptor modulators | May 20, 2015 | Issued |
Array
(
[id] => 11568591
[patent_doc_number] => 20170107234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'TRICYCLIC HETEROCYCLE DERIVATIVES HAVING HIV REPLICATION INHIBITORY EFFECT'
[patent_app_type] => utility
[patent_app_number] => 15/311757
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40195
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311757 | Tricyclic heterocycle derivatives having HIV replication inhibitory effect | May 14, 2015 | Issued |
Array
(
[id] => 12017050
[patent_doc_number] => 09809743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Condensed-cyclic compound and organic light-emitting device including the same'
[patent_app_type] => utility
[patent_app_number] => 14/713185
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19064
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/713185 | Condensed-cyclic compound and organic light-emitting device including the same | May 14, 2015 | Issued |
Array
(
[id] => 10448262
[patent_doc_number] => 20150333277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/712550
[patent_app_country] => US
[patent_app_date] => 2015-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7499
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14712550
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/712550 | Organic light emitting compound and organic light emitting device including the same | May 13, 2015 | Issued |
Array
(
[id] => 10444465
[patent_doc_number] => 20150329480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'ON-LINE ANALYSIS OF ACRYLONITRILE PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/710710
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4937
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14710710
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/710710 | On-line analysis of acrylonitrile product | May 12, 2015 | Issued |
Array
(
[id] => 11514230
[patent_doc_number] => 20170081304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'QUATERNARY AMMONIUM ALKYL ESTERS AS STABLE PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/310738
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310738 | Quaternary ammonium alkyl esters as stable prodrugs | May 11, 2015 | Issued |